Fortress Biotech, Inc. (FBIO)
1.94
+0.07
(+3.74%)
USD |
NASDAQ |
Oct 20, 16:00
1.91
-0.03
(-1.55%)
Pre-Market: 20:00
Fortress Biotech Gross Profit (TTM) : 40.31M for June 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 40.31M |
| March 31, 2026 | 39.12M |
| December 31, 2025 | 37.68M |
| September 30, 2025 | 37.51M |
| June 30, 2025 | 36.04M |
| March 31, 2025 | 33.67M |
| December 31, 2024 | 32.35M |
| September 30, 2024 | 36.59M |
| June 30, 2024 | 55.27M |
| March 31, 2024 | 56.13M |
| December 31, 2023 | 55.43M |
| September 30, 2023 | 49.74M |
| June 30, 2023 | 30.32M |
| March 31, 2023 | 32.00M |
| December 31, 2022 | 41.85M |
| September 30, 2022 | 41.98M |
| June 30, 2022 | 42.73M |
| March 31, 2022 | 41.99M |
| December 31, 2021 | 34.08M |
| September 30, 2021 | 34.95M |
| June 30, 2021 | 30.42M |
| March 31, 2021 | 26.40M |
| December 31, 2020 | 27.91M |
| September 30, 2020 | 26.11M |
| June 30, 2020 | 27.97M |
| Date | Value |
|---|---|
| March 31, 2020 | 28.64M |
| December 31, 2019 | 24.18M |
| September 30, 2019 | 20.49M |
| June 30, 2019 | 18.74M |
| March 31, 2019 | 16.56M |
| September 30, 2018 | 55.39M |
| June 30, 2018 | 97.89M |
| March 31, 2018 | 142.36M |
| December 31, 2017 | 181.84M |
| September 30, 2017 | 150.78M |
| June 30, 2017 | 105.69M |
| March 31, 2017 | 58.21M |
| December 31, 2016 | 14.50M |
| September 30, 2016 | 2.616M |
| June 30, 2016 | 1.836M |
| March 31, 2016 | -0.005M |
| December 31, 2015 | -0.005M |
| September 30, 2015 | -0.011M |
| June 30, 2015 | -0.017M |
| March 31, 2015 | -0.018M |
| December 31, 2014 | -0.023M |
| September 30, 2014 | -0.023M |
| June 30, 2014 | -0.021M |
| March 31, 2014 | -0.019M |
| December 31, 2013 | -0.017M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Inovio Pharmaceuticals, Inc. | -3.015M |
| Kura Oncology, Inc. | 75.37M |
| Spero Therapeutics, Inc. | 0.00 |
| ACADIA Pharmaceuticals, Inc. | 1.038B |
| Alnylam Pharmaceuticals, Inc. | 3.827B |